Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026)
Protagonist Therapeutics (PTGX) posted EPS (Basic) of $0.06 for Q1 2026, up 108.32% sequentially from -$0.7 in Q4 2025, and up 131.4% YoY from $0.03 in Q1 2025.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) EPS (Basic) (2015 - 2026) Analysis & Trends
Protagonist Therapeutics has reported EPS (Basic) for 12 years, with the latest figure at $0.06 in Q1 2026.
- Quarterly EPS (Basic) rose 131.4% year-over-year to $0.06 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.76 (down 297.65% YoY) and the FY2025 annual result came in at -$2.05, down 145.81% from the prior year.
- EPS (Basic) improved to $0.06 in Q1 2026 per PTGX's latest filing, from -$0.7 in the prior quarter.
- Over five years, EPS (Basic) peaked at $3.41 in Q1 2024 and troughed at -$1.37 in Q1 2022.
- A 5-year average of -$0.13 and a median of -$0.58 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) slumped 153.04% in 2022, then jumped 610.99% in 2024.
- Over 5 years, EPS (Basic) stood at -$0.71 in 2022, then soared by 208.59% to $0.77 in 2023, then jumped by 176.32% to $2.14 in 2024, then tumbled by 132.66% to -$0.7 in 2025, then surged by 108.32% to $0.06 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered $0.06, -$0.7, and -$0.62 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Protagonist Therapeutics | 9.61 Bn | 9.61 Bn | - | 2.47 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.47 |
| Mar 31, 2026 | 0.06 |
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.62 |
| Jun 30, 2025 | -0.55 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | 1.25 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.50 |
| Mar 31, 2024 | 3.41 |
| Dec 31, 2023 | 0.77 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -0.68 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -0.70 |
| Sep 30, 2022 | -0.63 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -0.43 |
| Dec 31, 2021 | -0.80 |
| Sep 30, 2021 | -0.70 |